Sarepta Therapeutics, Inc.
SRPT
$103.03
-$2.53-2.40%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 373.21% | 420.29% | -82.11% | -20.89% | 211.53% |
| Total Depreciation and Amortization | 6.62% | 12.47% | -0.29% | -23.11% | 4.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -53.63% | 127.08% | 5.79% | 10.53% | -44.86% |
| Change in Net Operating Assets | 42.30% | -377.37% | 86.23% | -119.32% | 2.86% |
| Cash from Operations | 230.19% | -573.16% | 106.17% | -342.90% | 52.35% |
| Capital Expenditure | -2.20% | -27.76% | 10.10% | -70.41% | 35.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 976.13% | -32.01% | -127.61% | 654.38% | 74.95% |
| Cash from Investing | 693.14% | -30.75% | -145.03% | 439.97% | 69.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -73.03% | -65.54% | 80.30% | 1,039.48% | -87.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 256.12% | -65.54% | 80.30% | 1,039.48% | -87.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 587.25% | -325.41% | -3,730.53% | 99.03% | 62.22% |
